539997.BO WACC - Weighted Average Cost of Capital

The WACC of Kwality Pharmaceuticals Ltd (539997.BO) is 13.1%.

The Cost of Equity of Kwality Pharmaceuticals Ltd (539997.BO) is 13.75%.

The Cost of Debt of Kwality Pharmaceuticals Ltd (539997.BO) is 8.90%.

	Range	Selected
Cost of equity	12.00% - 15.50%	13.75%
Tax rate	25.30% - 26.10%	25.70%
Cost of debt	7.90% - 9.90%	8.90%
WACC	11.4% - 14.8%	13.1%

WACC

539997.BO WACC calculation

Category	Low	High

Long-term bond rate	6.9%	7.4%
Equity market risk premium	8.3%	9.3%
Adjusted beta	0.61	0.82

Additional risk adjustments	0.0%	0.5%
Cost of equity	12.00%	15.50%

Tax rate	25.30%	26.10%
Debt/Equity ratio	0.09	0.09
Cost of debt	7.90%	9.90%

After-tax WACC	11.4%	14.8%


Selected WACC	13.1%

539997.BO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 539997.BO:

cost_of_equity (13.75%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.61) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.